Oct 31, 2024 09:00AM
Oct 24, 2024 09:00AM
Oct 21, 2024 09:01AM
Oct 21, 2024 09:00AM
Oct 14, 2024 09:19AM
Oct 14, 2024 09:18AM
Aug 14, 2024 09:00AM INVO Reports Record Second Quarter 2024 Financial Results with 481% Revenue Growth and a $1.1 Million Improvement to Adjusted EBITDA
May 15, 2024 04:15PM
Apr 16, 2024 04:59PM
Jan 23, 2024 08:08AM
Jan 23, 2024 08:00AM
Dec 11, 2023 08:00AM
Dec 6, 2023 09:00AM
Nov 28, 2023 09:00AM INVO Bioscience Regains Compliance with Nasdaq Minimum Stockholders' Equity Requirement
Nov 13, 2023 04:01PM
Nov 10, 2023 09:01AM
Nov 10, 2023 09:00AM
Nov 9, 2023 04:40PM
Oct 27, 2023 09:00AM
Oct 23, 2023 07:32AM
Oct 23, 2023 07:30AM INVO Bioscience and NAYA Biosciences Announce Definitive Merger Agreement To Establish Expanded Publicly Traded Life Science Company
Oct 11, 2023 09:00AM
Sep 29, 2023 04:05PM
Sep 28, 2023 12:30PM
Aug 14, 2023 04:05PM
Aug 11, 2023 08:00AM
Aug 9, 2023 04:15PM
Aug 8, 2023 01:55PM INVO Bioscience Announces Closing of $4.5 Million Public Offering
Aug 4, 2023 09:00AM
Aug 4, 2023 09:00AM
Aug 3, 2023 08:00AM
Jun 27, 2023 09:01AM
Jun 27, 2023 09:00AM
May 15, 2023 04:05PM
Apr 17, 2023 04:05PM INVO Reports Fourth Quarter and Full Year 2022 Financial Results
Apr 11, 2023 05:30PM
Apr 5, 2023 09:00AM
Mar 30, 2023 05:25PM
Mar 20, 2023 09:01AM
Mar 20, 2023 09:00AM
Jan 3, 2023 09:00AM
Dec 6, 2022 04:28PM U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.03%
Nov 30, 2022 09:30AM
Nov 14, 2022 04:05PM
Nov 1, 2022 09:00AM
Aug 15, 2022 04:05PM
Mar 31, 2022 04:05PM
Nov 15, 2021 04:05PM
Nov 8, 2021 04:56PM INVO Bioscience (INVO) Regains Full Commercialization Rights in the US
Nov 8, 2021 04:15PM

1,122,779 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All